Reduced serum levels of Interleukin 17 in patients with osteonecrosis of the jaw and in multiple myeloma subjects after bisphosphonates administration

Cytokine

Volumn 43, Issue 2, 2008, Pages 103-104

  Oteri, Giacomo ^a   Allegra, Alessandro ^a   Bellomo, Giacomo ^a   Alonci, Andrea ^a   Nastro, Enrico ^a   Penna, Giuseppa ^a   Catalfamo, Luciano ^a   Cicciù, Domenico ^a   Ponte, Francesco Saverio De ^a   Musolino, Caterina ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; INTERLEUKIN 17; PAMIDRONIC ACID; VASCULOTROPIN; ZOLEDRONIC ACID;

ADULT; AGED; ANGIOGENESIS; BLOOD SAMPLING; BONE NECROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; JAW OSTEONECROSIS; LETTER; MALE; MICROVASCULATURE; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT DURATION;

AGED; DIPHOSPHONATES; FEMALE; HUMANS; INTERLEUKIN-17; JAW DISEASES; MALE; MIDDLE AGED; MULTIPLE MYELOMA; OSTEONECROSIS;

EID: 48149112128     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.05.010     Document Type: Letter

References (9)

1. Nastro E., Musolino C., Allegra A., Cicciù M., Alonci A., Quartarone E., et al. Bisphosphonate-associated osteonecrosis of the jaw in patients with multiple myeloma and breast cancer. Acta Haematol 117 (2007) 181-187
2. Wood J., Bongean K., Ruetz S., et al. Novel antiangiogenic effects of the bisphosphonates compound zoledronic acid. J Pharm Exp Ther 302 (2002) 1055
3. Allegra A., Oteri G., Nastro E., Alonci A., Bellomo G., Del Fabro V., et al. Patients with bisphosphonates-associated osteonecrosis of the jaw have reduced circulating endothelial cells. Hematol Oncol 25 (2007) 1-6
4. Alonci A., Allegra A., Bellomo G., Quartarone E., Oteri G., Nastro E., et al. Patients with bisphosphonate-associated osteonecrosis of the jaw have unmodified levels of soluble vascular endothelial growth factor receptor 1. Leuk Lymph 48 (2007) 1852-1854
5. Numasaki M., Fukushi J., Ono M., Narula S.K., Zavodny P.J., Kudo T., et al. Interleukin-17 promotes angiogenesis and tumor growth. Blood 101 (2003) 2620-2627
6. Johnson R.B., Wood N., and Serio F.G. Interleukin-11 and IL-17 and the pathogenesis of periodontal disease. J Periodontol 75 (2004) 37-43
7. McCauley L.K. Transgenic mouse models of metabolic bone disease. Curr Opin Rheumatol 13 (2001) 316-325
8. Alexandrakis M.G., Pappa C.A., Miyakis S., Sfiridaki A., Kafousi M., Alegakis A., et al. Serum interleukin-17 and its relationship to angiogenic factors in multiple myeloma. Eur J Intern Med 17 (2006) 412-416
9. Gerber H.P., Vu T.H., Ryan A.M., Kowalski J., Werb Z., and Ferrara N. VEGF couples hypertrofic cartilage remodelling, ossification and angiogenesis during endochondral bone formation. Nat Med 5 (1999) 623-662